Birzeit Pharmaceuticals Company (PEX:BPC)

PEX:BPC Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.49	3.07	3.11	3	1.14	2.55
Short-Term Investments	0.5	0.5	0.5	-	-	1.5
Trading Asset Securities	3.02	11.93	13.58	13.63	12.67	8.64
Cash & Short-Term Investments	5.02	15.5	17.19	16.63	13.81	12.69
Cash Growth	-63.40%	-9.81%	3.38%	20.39%	8.82%	-8.58%
Accounts Receivable	39.54	40.74	34.53	37.47	31.74	22.66
Other Receivables	1.26	1.35	2.13	-	1.19	1.35
Receivables	40.8	42.08	36.66	37.47	32.93	24.01
Inventory	12.73	11.84	13.13	12.2	11.65	12.19
Prepaid Expenses	-	0.27	0.14	-	0.11	0.11
Other Current Assets	0.32	0.37	0.07	1.92	1.12	1.11
Total Current Assets	58.87	70.06	67.19	68.22	59.62	50.11
Property, Plant & Equipment	30.57	29.49	24.31	22.47	21.13	22.07
Long-Term Investments	31.69	27.15	26.97	25.5	24.07	19.7
Long-Term Accounts Receivable	0.7	0.65	0.06	0.05	0.45	-
Long-Term Deferred Tax Assets	1.23	1.21	1.27	1.15	1.1	1.03
Other Long-Term Assets	0.45	0.27	5.35	5.61	5.61	6.14
Total Assets	123.5	128.82	125.15	123	111.98	99.06
Accounts Payable	9.79	3.7	2.03	-	1.59	2.05
Accrued Expenses	-	2.03	2.18	-	2.31	1.58
Current Portion of Long-Term Debt	-	-	-	0.42	0.85	1.17
Other Current Liabilities	-	7.11	3.97	7.15	2.42	2.52
Total Current Liabilities	9.79	12.85	8.18	7.57	7.18	7.32
Long-Term Debt	-	-	-	0.8	1.18	2.03
Total Liabilities	21.19	23.94	20.12	19.49	19.18	19.33
Common Stock	38.76	38.76	38.76	38.76	19.38	19
Retained Earnings	65.1	63.76	60.52	58.14	70.39	61.54
Treasury Stock	-0.19	-0.23	-0.23	-0.23	-0.15	-0.14
Comprehensive Income & Other	-1.96	1.9	5.27	5.91	2.24	-1.53
Total Common Equity	101.71	104.2	104.32	102.59	91.86	78.87
Minority Interest	0.6	0.68	0.7	0.92	0.93	0.86
Shareholders' Equity	102.31	104.88	105.02	103.51	92.79	79.73
Total Liabilities & Equity	123.5	128.82	125.15	123	111.98	99.06
Total Debt	-	-	-	1.22	2.03	3.2
Net Cash (Debt)	5.02	15.5	17.19	15.41	11.78	9.49
Net Cash Growth	-63.40%	-9.81%	11.53%	30.87%	24.09%	-0.26%
Net Cash Per Share	0.13	0.40	0.44	0.41	0.30	0.24
Filing Date Shares Outstanding	38.71	38.76	38.71	35.24	38.76	38.76
Total Common Shares Outstanding	38.71	38.76	38.71	35.24	38.76	38.76
Working Capital	49.08	57.21	59.01	60.65	52.44	42.79
Book Value Per Share	2.63	2.69	2.69	2.91	2.37	2.03
Tangible Book Value	101.71	104.2	104.32	102.59	91.86	78.87
Tangible Book Value Per Share	2.63	2.69	2.69	2.91	2.37	2.03
Land	-	9.03	3.95	-	3.58	3.61
Buildings	-	11.71	11.71	-	12.24	12.2
Machinery	-	41.48	41.19	-	40.56	39.97
Construction In Progress	-	7.26	6.04	-	0.44	0.35

Updated Feb 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.